Home
Categories
EXPLORE
Music
True Crime
History
News
Society & Culture
Business
Education
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/cb/97/f8/cb97f8db-8e8b-8e16-54d2-b196f74fb263/mza_10016186607092210186.jpg/600x600bb.jpg
The long and short of it
GraniteShares Europe
11 episodes
1 week ago
A look at what's moving markets and stock prices, generally jargon free but it's finance so there will be some legal disclaimers like capital at risk
Show more...
Investing
Business
RSS
All content for The long and short of it is the property of GraniteShares Europe and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A look at what's moving markets and stock prices, generally jargon free but it's finance so there will be some legal disclaimers like capital at risk
Show more...
Investing
Business
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/5031605/5031605-1587995514376-7444b0e233947.jpg
Back on the big dipper
The long and short of it
7 minutes 25 seconds
5 years ago
Back on the big dipper

Some insights into what caused markets to tumble last week, focusing on concerns about a second wave of the pandemic and a dovish Federal Reserve.  It was a week when many stocks delivered negative returns and in relative terms it was the defensive stocks that performed best.  Stocks mentioned this week include AstraZeneca, which is signing more agreements for the distribution of Oxford University's Covid-19 vaccine, and BP, which is looking to reduce its workforce by 15% and is looking to make some big write-offs in Q2.  Listen to find out more.

The long and short of it
A look at what's moving markets and stock prices, generally jargon free but it's finance so there will be some legal disclaimers like capital at risk